Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome

Ji Hee Kim, Kyu Hee Hwang, Sayamaa Lkhagvadorj, Jae Hung Jung, Hyun Chul Chung, Kyu Sang Park, In Deok Kong, Minseob Eom, Seung Kuy Cha

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Klotho functions as a tumor suppressor predominantly expressed in renal tubular cells, the origin of clear cell renal cell carcinoma (ccRCC). Altered expression and/or activity of growth factor receptor have been implicated in ccRCC development. Although Klotho suppresses a tumor progression through growth factor receptor signaling including insulin-like growth factor-1 receptor (IGF-1R), the role of Klotho acting on IGF-1R in ccRCC and its clinical relevance remains obscure. Here, we show that Klotho is favorable prognostic factor for ccRCC and exerts tumor suppressive role for ccRCC through inhibiting IGF-1R signaling. Our data shows the following key findings. First, in tumor tissues, the level of Klotho and IGF-1R expression are low or high, respectively, compared to that of adjacent non-neoplastic parenchyma. Second, the Klotho expression is clearly low in higher grade of ccRCC and is closely associated with clinical outcomes in tumor progression. Third, Klotho suppresses IGF-1-stimulated cell proliferation and migration by inhibiting PI3K/Akt pathway. These results provide compelling evidence supporting that Klotho acting on IGF-1R signaling functions as tumor suppressor in ccRCC and suggest that Klotho is a potential carcinostatis substance for ccRCC.

Original languageEnglish
Pages (from-to)297-304
Number of pages8
JournalKorean Journal of Physiology and Pharmacology
Volume20
Issue number3
DOIs
Publication statusPublished - 2016 May

Fingerprint

Renal Cell Carcinoma
Somatomedin Receptors
Neoplasms
Growth Factor Receptors
Phosphatidylinositol 3-Kinases
Insulin-Like Growth Factor I
Cell Movement
Cell Proliferation
Kidney

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pharmacology

Cite this

@article{af20882b63b947b6833cc26e9409f0fb,
title = "Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome",
abstract = "Klotho functions as a tumor suppressor predominantly expressed in renal tubular cells, the origin of clear cell renal cell carcinoma (ccRCC). Altered expression and/or activity of growth factor receptor have been implicated in ccRCC development. Although Klotho suppresses a tumor progression through growth factor receptor signaling including insulin-like growth factor-1 receptor (IGF-1R), the role of Klotho acting on IGF-1R in ccRCC and its clinical relevance remains obscure. Here, we show that Klotho is favorable prognostic factor for ccRCC and exerts tumor suppressive role for ccRCC through inhibiting IGF-1R signaling. Our data shows the following key findings. First, in tumor tissues, the level of Klotho and IGF-1R expression are low or high, respectively, compared to that of adjacent non-neoplastic parenchyma. Second, the Klotho expression is clearly low in higher grade of ccRCC and is closely associated with clinical outcomes in tumor progression. Third, Klotho suppresses IGF-1-stimulated cell proliferation and migration by inhibiting PI3K/Akt pathway. These results provide compelling evidence supporting that Klotho acting on IGF-1R signaling functions as tumor suppressor in ccRCC and suggest that Klotho is a potential carcinostatis substance for ccRCC.",
author = "Kim, {Ji Hee} and Hwang, {Kyu Hee} and Sayamaa Lkhagvadorj and Jung, {Jae Hung} and Chung, {Hyun Chul} and Park, {Kyu Sang} and Kong, {In Deok} and Minseob Eom and Cha, {Seung Kuy}",
year = "2016",
month = "5",
doi = "10.4196/kjpp.2016.20.3.297",
language = "English",
volume = "20",
pages = "297--304",
journal = "Korean Journal of Physiology and Pharmacology",
issn = "1226-4512",
publisher = "Korean Physiological Soc. and Korean Soc. of Pharmacology",
number = "3",

}

Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome. / Kim, Ji Hee; Hwang, Kyu Hee; Lkhagvadorj, Sayamaa; Jung, Jae Hung; Chung, Hyun Chul; Park, Kyu Sang; Kong, In Deok; Eom, Minseob; Cha, Seung Kuy.

In: Korean Journal of Physiology and Pharmacology, Vol. 20, No. 3, 05.2016, p. 297-304.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome

AU - Kim, Ji Hee

AU - Hwang, Kyu Hee

AU - Lkhagvadorj, Sayamaa

AU - Jung, Jae Hung

AU - Chung, Hyun Chul

AU - Park, Kyu Sang

AU - Kong, In Deok

AU - Eom, Minseob

AU - Cha, Seung Kuy

PY - 2016/5

Y1 - 2016/5

N2 - Klotho functions as a tumor suppressor predominantly expressed in renal tubular cells, the origin of clear cell renal cell carcinoma (ccRCC). Altered expression and/or activity of growth factor receptor have been implicated in ccRCC development. Although Klotho suppresses a tumor progression through growth factor receptor signaling including insulin-like growth factor-1 receptor (IGF-1R), the role of Klotho acting on IGF-1R in ccRCC and its clinical relevance remains obscure. Here, we show that Klotho is favorable prognostic factor for ccRCC and exerts tumor suppressive role for ccRCC through inhibiting IGF-1R signaling. Our data shows the following key findings. First, in tumor tissues, the level of Klotho and IGF-1R expression are low or high, respectively, compared to that of adjacent non-neoplastic parenchyma. Second, the Klotho expression is clearly low in higher grade of ccRCC and is closely associated with clinical outcomes in tumor progression. Third, Klotho suppresses IGF-1-stimulated cell proliferation and migration by inhibiting PI3K/Akt pathway. These results provide compelling evidence supporting that Klotho acting on IGF-1R signaling functions as tumor suppressor in ccRCC and suggest that Klotho is a potential carcinostatis substance for ccRCC.

AB - Klotho functions as a tumor suppressor predominantly expressed in renal tubular cells, the origin of clear cell renal cell carcinoma (ccRCC). Altered expression and/or activity of growth factor receptor have been implicated in ccRCC development. Although Klotho suppresses a tumor progression through growth factor receptor signaling including insulin-like growth factor-1 receptor (IGF-1R), the role of Klotho acting on IGF-1R in ccRCC and its clinical relevance remains obscure. Here, we show that Klotho is favorable prognostic factor for ccRCC and exerts tumor suppressive role for ccRCC through inhibiting IGF-1R signaling. Our data shows the following key findings. First, in tumor tissues, the level of Klotho and IGF-1R expression are low or high, respectively, compared to that of adjacent non-neoplastic parenchyma. Second, the Klotho expression is clearly low in higher grade of ccRCC and is closely associated with clinical outcomes in tumor progression. Third, Klotho suppresses IGF-1-stimulated cell proliferation and migration by inhibiting PI3K/Akt pathway. These results provide compelling evidence supporting that Klotho acting on IGF-1R signaling functions as tumor suppressor in ccRCC and suggest that Klotho is a potential carcinostatis substance for ccRCC.

UR - http://www.scopus.com/inward/record.url?scp=84968845819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968845819&partnerID=8YFLogxK

U2 - 10.4196/kjpp.2016.20.3.297

DO - 10.4196/kjpp.2016.20.3.297

M3 - Article

AN - SCOPUS:84968845819

VL - 20

SP - 297

EP - 304

JO - Korean Journal of Physiology and Pharmacology

JF - Korean Journal of Physiology and Pharmacology

SN - 1226-4512

IS - 3

ER -